ClinicalTrials.gg

Cachexia clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 331 studies for Cachexia across more than 10 countries. 74 are recruiting or about to start. 144 of them are mainly about Cachexia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Status

Completed
172
Recruiting
55
Status unknown
36
Terminated
26
Not yet recruiting
16
Active, not recruiting
12

Phase

Phase 2
61
Phase 3
36
Phase 1
35
Phase 4
6
Early Phase 1
4

Where

United States
95
China
29
United Kingdom
23
Germany
21
Canada
17
France
15

Who develops what

Add Cachexia to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 13 programs from 13 companies, 12 with this as their studies’ main aim; 4 with a live phase 3 study; 5 primary completions in the next 12 months. Compare Changchun GeneScience Pharmaceutical, Genfleet Therapeutics (Shanghai) and LG Chem here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
Megestrol AcetatePhase 4 trial recorded☆ Track1 live phase-3 study: NCT07356037Changchun GeneScience Pharmaceutical Co., Ltd.
ponsegromab☆ Track1 live phase-3 study: NCT06989437Pfizer
visugromab☆ Track1 live phase-3 study: NCT07112196CatalYm GmbH
rilogrotug☆ Track1 live phase-3 study: NCT07888075LG Chem

The 4 in phase 3 with the nearest primary completion, of 13 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (5)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 31 Dec 2026 est.Megestrol Acetate · Changchun GeneScience Pharmaceutical Co., Ltd. · Phase 4 main aimNCT07243379 A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia — primary endpoint: Proportion of patients with improved appetite at Week 4 based on the A/CS-12 scale. · 495 enrolled
  • 30 Jun 2027 est.Megestrol Acetate · Changchun GeneScience Pharmaceutical Co., Ltd. · Phase 3 main aimNCT07356037 Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma — primary endpoint: The proportion of subjects with improved appetite based on A/CS-12 assessment. · 68 enrolled
  • Aug 2027 est.SXRN Injection · Jiangsu Guiqiong Pharmaceutical Co., Ltd. · Phase 2 main aimNCT07890324 A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia — primary endpoint: Change in anorexia from baseline at Week 3 · 96 enrolled

2 more — sign in to see them all, free.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Cachexia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here NSAIDs 4 · Androgens 3

Coming up

30studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 55 Cachexia studies recruiting now, 32 (58%) set no upper age limit and 14 (25%) stop at 75 or younger. 7 (13%) take children under 18. 3 (5%) are for women only and 0 (0%) for men only; 16 (29%) take healthy volunteers.

Recruiting studies that take each age, of 55
AgeWomenMen
100 (0%)0 (0%)
1844 (80%)41 (75%)
3046 (84%)43 (78%)
4047 (85%)44 (80%)
5046 (84%)45 (82%)
6544 (80%)43 (78%)
7544 (80%)43 (78%)
8538 (69%)37 (67%)

Across all 331 studies, recruiting or not: 31% stop at 75 or younger and 23% at 65; 22% take children; 5% are for women only and 2% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cachexia studies take

Of 21 phase 1 interventional studies under Cachexia, half reached primary completion within 11 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 111 mo8–25 · 21 studies——
Interventional, no phase19 mo12–48 · 77 studies—19 mo11–48 · 75 studies
Observational38 mo19–48 · 38 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 17, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 331. Browse all 331 → or search them.